The Company saw an increase in revenue Rs. 2604 crores by 8% for the quarter compared to last quarter. Agrochemicals firm Rallis India declares Q4FY22 result: Consolidated Revenues for FY22 at Rs. 2604 crores, up 7.2% YoY Consolidated PAT for FY22 at 164 crores Board recommends a dividend of Rs 3.0 per share Consolidated Key Highlights – Q4 The Company recorded consolidated revenues of Rs 508 Cr for the quarter ended 31 March 2022, an increase of 8% over PY of Rs 471 Cr. Loss before tax (before exceptional items) was at (Rs 16) Cr as compared to PY of profit before tax (before exceptional item) of Rs 10 Cr and the Loss after tax (after exceptional items) was (Rs 14) Cr, as compared to PY profit after tax (after exceptional item) of Rs 8 Cr. Consolidated Key Highlights – 12M ending 31st March 2022 The Company recorded consolidated revenues of Rs 2604 Cr for the period ended 31 March 2022, a growth of 7.2% over PY of Rs 2429 Cr. Profit before tax (before exceptional items) was at Rs 222 Cr, with a decline of 24% over PY of Rs 294 Cr and the profit after tax (after exceptional items) was Rs 164 Cr, registering a decline of 28% over PY of Rs 229 Cr. Mr. Sanjiv Lal, Managing Director, and CEO, Rallis India said, “The Company delivered a resilient performance in the wake of multiple headwinds during the year. Our domestic crop care business grew at 14.0% and exports by 6.2% during the year. Our seeds business faced challenges and revenue declined by 13%. Supply chain challenges continued into Q4 with availability issues for certain intermediates as well as steep cost inflation. We are focussed on minimising the disruptions to our production as much as possible. Calibrated price corrections have helped in partially neutralising the material cost inflation. On the positive side, predictions of normal monsoons and robust commodity prices both locally and globally are expected to have a favourable impact on Indian agriculture. Moving forward we are focused on growth despite the volatile context. On a longer-term basis, our capex plans, new product introduction plans, and demand generation investments remain on course as we believe that normalcy will be restored progressively. While doing this, we are also consistently prioritising the safety and well-being of all our employees and other stakeholders.” Result PDF
Conference Call with Rallis India Ltd. Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.
Agrochemicals company Rallis India declares Q3FY22 result: Rallis India reports Consolidated Revenues at Rs 2096 Crore, 7.1% YoY Consolidated PAT at Rs 178 Crore The Company recorded consolidated revenues of Rs 2096 Cr for the period ended 31 December, 2021, a growth of 7.1% over PY of Rs 1958 Cr. Profit before tax (before exceptional items) was at Rs 239 Cr, with a decline of 16% over PY of Rs 284 Cr and the profit after tax (after exceptional items) was Rs 178 Cr, registering a decline of 19.1% over PY of Rs 220 Cr. The Company recorded consolidated revenues of Rs 628 Cr for the quarter ended 31 December, 2021, a growth of 10.1% over PY of Rs 570 Cr. Profit before tax (before exceptional items) was at Rs 53 Cr, with a decline of 5.1% over PY of Rs 56 Cr and the profit after tax (after exceptional items) was Rs 40 Cr, registering a decline of 13.3% over PY of Rs 246 Cr. Announcing the results, Mr. Sanjiv Lal, Managing Director and CEO, Rallis India said, “The erratic monsoon season this year has not favoured agri input companies as excessive rainfall continued into Q3 in the southern states. Despite these challenges, our domestic crop care business grew at 9.4%, and exports by 19% during the quarter. The Seeds Industry continued to face headwinds due to restrictions for sale of paddy and maize hybrids in some states. Supply chain challenges continued into Q3 with availability being a challenge for certain intermediates as well as steep inflation in prices. We are focussed on minimising the disruptions to our production as much as possible and calibrated price corrections have helped in partially neutralizing the RM cost inflation. On a longer term basis, our capex plans, new product introduction plans and demand generation investments remain on course as we do believe that normalcy will be restored progressively. While positioning ourselves so, we are also consistently prioritising the safety and well-being of all our employees and other stakeholders.” Result PDF